Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

Objective: This study assesses the effects of insulin pump therapy on diabetes control and family life in children 1 6 years old with type 1 diabetes. Research Design and Methods: Twenty-six ...

PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors.

PharmaSens, a developer of insulin patch pumps for people with diabetes, has appointed Robert A. Gabbay, MD, PhD, FACP and James L. Peterson to its board of directors.

Hybrid closed-loop insulin therapy prevents low night-time blood glucose levels among breastfeeding mothers with type 1 ...

For Dr. Daniel Gilada, a husband, physician and soon-to-be father of four, living with Type 1 diabetes had become ...

1 mylife Loop consists of the mylife YpsoPump, a lightweight intuitive insulin pump, integrated with the CamAPS FX hybrid ...

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because ... unexpectedly stop therapy. Medtronic, which has ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

The rising popularity of the continuous glucose monitor, which is not the same as an insulin pump, has been a huge advance in ...

Marlaina Goedel, diagnosed at age 5, said she is no longer on insulin. For Dr. Daniel Gilada, a husband, physician and soon-to-be father of four, living with Type 1 diabetes had become ...